MANHATTAN ASSOCIATES INC (MANH) Fundamental Analysis & Valuation

NASDAQ:MANH • US5627501092

Current stock price

140.62 USD
-0.61 (-0.43%)
At close:
140.62 USD
0 (0%)
After Hours:

This MANH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. MANH Profitability Analysis

1.1 Basic Checks

  • In the past year MANH was profitable.
  • In the past year MANH had a positive cash flow from operations.
  • Each year in the past 5 years MANH has been profitable.
  • MANH had a positive operating cash flow in each of the past 5 years.
MANH Yearly Net Income VS EBIT VS OCF VS FCFMANH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • MANH's Return On Assets of 26.20% is amongst the best of the industry. MANH outperforms 98.56% of its industry peers.
  • With an excellent Return On Equity value of 69.88%, MANH belongs to the best of the industry, outperforming 97.83% of the companies in the same industry.
  • MANH's Return On Invested Capital of 58.53% is amongst the best of the industry. MANH outperforms 98.92% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MANH is significantly above the industry average of 10.87%.
  • The last Return On Invested Capital (58.53%) for MANH is above the 3 year average (56.95%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 26.2%
ROE 69.88%
ROIC 58.53%
ROA(3y)27.08%
ROA(5y)24.87%
ROE(3y)68.78%
ROE(5y)61.46%
ROIC(3y)56.95%
ROIC(5y)51.03%
MANH Yearly ROA, ROE, ROICMANH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • MANH's Profit Margin of 20.34% is amongst the best of the industry. MANH outperforms 87.00% of its industry peers.
  • MANH's Profit Margin has improved in the last couple of years.
  • MANH has a Operating Margin of 26.15%. This is amongst the best in the industry. MANH outperforms 91.34% of its industry peers.
  • MANH's Operating Margin has improved in the last couple of years.
  • MANH has a worse Gross Margin (56.32%) than 64.26% of its industry peers.
  • In the last couple of years the Gross Margin of MANH has remained more or less at the same level.
Industry RankSector Rank
OM 26.15%
PM (TTM) 20.34%
GM 56.32%
OM growth 3Y9.51%
OM growth 5Y6.09%
PM growth 3Y6.54%
PM growth 5Y6.46%
GM growth 3Y1.86%
GM growth 5Y0.86%
MANH Yearly Profit, Operating, Gross MarginsMANH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. MANH Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MANH is creating value.
  • The number of shares outstanding for MANH has been reduced compared to 1 year ago.
  • The number of shares outstanding for MANH has been reduced compared to 5 years ago.
  • There is no outstanding debt for MANH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MANH Yearly Shares OutstandingMANH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
MANH Yearly Total Debt VS Total AssetsMANH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 12.82 indicates that MANH is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 12.82, MANH belongs to the top of the industry, outperforming 94.22% of the companies in the same industry.
  • There is no outstanding debt for MANH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.82
ROIC/WACC5.42
WACC10.79%
MANH Yearly LT Debt VS Equity VS FCFMANH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

  • MANH has a Current Ratio of 1.28. This is a normal value and indicates that MANH is financially healthy and should not expect problems in meeting its short term obligations.
  • MANH's Current ratio of 1.28 is on the low side compared to the rest of the industry. MANH is outperformed by 61.73% of its industry peers.
  • MANH has a Quick Ratio of 1.28. This is a normal value and indicates that MANH is financially healthy and should not expect problems in meeting its short term obligations.
  • MANH has a Quick ratio of 1.28. This is in the lower half of the industry: MANH underperforms 60.65% of its industry peers.
  • MANH does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.28
MANH Yearly Current Assets VS Current LiabilitesMANH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. MANH Growth Analysis

3.1 Past

  • MANH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.19%.
  • The Earnings Per Share has been growing by 23.57% on average over the past years. This is a very strong growth
  • MANH shows a small growth in Revenue. In the last year, the Revenue has grown by 3.75%.
  • The Revenue has been growing by 13.02% on average over the past years. This is quite good.
EPS 1Y (TTM)7.19%
EPS 3Y22.47%
EPS 5Y23.57%
EPS Q2Q%3.42%
Revenue 1Y (TTM)3.75%
Revenue growth 3Y12.13%
Revenue growth 5Y13.02%
Sales Q2Q%5.7%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.98% on average over the next years. This is quite good.
  • MANH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.85% yearly.
EPS Next Y4.92%
EPS Next 2Y8.76%
EPS Next 3Y9.79%
EPS Next 5Y18.98%
Revenue Next Year6.47%
Revenue Next 2Y7.63%
Revenue Next 3Y8.05%
Revenue Next 5Y8.85%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MANH Yearly Revenue VS EstimatesMANH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
MANH Yearly EPS VS EstimatesMANH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

4

4. MANH Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 27.74, the valuation of MANH can be described as expensive.
  • Based on the Price/Earnings ratio, MANH is valued a bit cheaper than the industry average as 60.65% of the companies are valued more expensively.
  • MANH's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.96.
  • With a Price/Forward Earnings ratio of 26.44, MANH can be considered very expensive at the moment.
  • MANH's Price/Forward Earnings ratio is in line with the industry average.
  • When comparing the Price/Forward Earnings ratio of MANH to the average of the S&P500 Index (24.04), we can say MANH is valued inline with the index average.
Industry RankSector Rank
PE 27.74
Fwd PE 26.44
MANH Price Earnings VS Forward Price EarningsMANH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • MANH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MANH is cheaper than 68.59% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of MANH indicates a somewhat cheap valuation: MANH is cheaper than 68.95% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.5
EV/EBITDA 28.11
MANH Per share dataMANH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • MANH has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)5.64
PEG (5Y)1.18
EPS Next 2Y8.76%
EPS Next 3Y9.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MANH Dividend Analysis

5.1 Amount

  • MANH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MANH Fundamentals: All Metrics, Ratios and Statistics

MANHATTAN ASSOCIATES INC

NASDAQ:MANH (3/17/2026, 4:30:00 PM)

After market: 140.62 0 (0%)

140.62

-0.61 (-0.43%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)01-27
Earnings (Next)04-20
Inst Owners105.66%
Inst Owner Change-2.41%
Ins Owners1.18%
Ins Owner Change-1.47%
Market Cap8.42B
Revenue(TTM)1.08B
Net Income(TTM)219.95M
Analysts83.16
Price Target217.19 (54.45%)
Short Float %4.25%
Short Ratio2.91
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.54%
Min EPS beat(2)5.72%
Max EPS beat(2)13.36%
EPS beat(4)4
Avg EPS beat(4)11.67%
Min EPS beat(4)5.72%
Max EPS beat(4)13.93%
EPS beat(8)8
Avg EPS beat(8)14.56%
EPS beat(12)12
Avg EPS beat(12)18.24%
EPS beat(16)16
Avg EPS beat(16)21.82%
Revenue beat(2)0
Avg Revenue beat(2)-0.34%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)-0.17%
Revenue beat(4)2
Avg Revenue beat(4)0.26%
Min Revenue beat(4)-0.51%
Max Revenue beat(4)1.26%
Revenue beat(8)4
Avg Revenue beat(8)0.46%
Revenue beat(12)8
Avg Revenue beat(12)1.99%
Revenue beat(16)12
Avg Revenue beat(16)2.69%
PT rev (1m)-2.09%
PT rev (3m)-5.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.9%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE 27.74
Fwd PE 26.44
P/S 7.78
P/FCF 22.5
P/OCF 21.61
P/B 26.74
P/tB 33.33
EV/EBITDA 28.11
EPS(TTM)5.07
EY3.61%
EPS(NY)5.32
Fwd EY3.78%
FCF(TTM)6.25
FCFY4.44%
OCF(TTM)6.51
OCFY4.63%
SpS18.07
BVpS5.26
TBVpS4.22
PEG (NY)5.64
PEG (5Y)1.18
Graham Number24.49
Profitability
Industry RankSector Rank
ROA 26.2%
ROE 69.88%
ROCE 73.73%
ROIC 58.53%
ROICexc 410.13%
ROICexgc N/A
OM 26.15%
PM (TTM) 20.34%
GM 56.32%
FCFM 34.59%
ROA(3y)27.08%
ROA(5y)24.87%
ROE(3y)68.78%
ROE(5y)61.46%
ROIC(3y)56.95%
ROIC(5y)51.03%
ROICexc(3y)364.11%
ROICexc(5y)380.76%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)71.74%
ROCE(5y)64.28%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-0.52%
ROICexc growth 5Y23.6%
OM growth 3Y9.51%
OM growth 5Y6.09%
PM growth 3Y6.54%
PM growth 5Y6.46%
GM growth 3Y1.86%
GM growth 5Y0.86%
F-Score7
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 244.69%
Cap/Sales 1.43%
Interest Coverage 250
Cash Conversion 134.74%
Profit Quality 170.05%
Current Ratio 1.28
Quick Ratio 1.28
Altman-Z 12.82
F-Score7
WACC10.79%
ROIC/WACC5.42
Cap/Depr(3y)154.87%
Cap/Depr(5y)122.75%
Cap/Sales(3y)0.92%
Cap/Sales(5y)0.85%
Profit Quality(3y)145.98%
Profit Quality(5y)147.21%
High Growth Momentum
Growth
EPS 1Y (TTM)7.19%
EPS 3Y22.47%
EPS 5Y23.57%
EPS Q2Q%3.42%
EPS Next Y4.92%
EPS Next 2Y8.76%
EPS Next 3Y9.79%
EPS Next 5Y18.98%
Revenue 1Y (TTM)3.75%
Revenue growth 3Y12.13%
Revenue growth 5Y13.02%
Sales Q2Q%5.7%
Revenue Next Year6.47%
Revenue Next 2Y7.63%
Revenue Next 3Y8.05%
Revenue Next 5Y8.85%
EBIT growth 1Y8.08%
EBIT growth 3Y22.8%
EBIT growth 5Y19.9%
EBIT Next Year8.14%
EBIT Next 3Y9.69%
EBIT Next 5Y13.03%
FCF growth 1Y30.62%
FCF growth 3Y29.3%
FCF growth 5Y22.03%
OCF growth 1Y32.02%
OCF growth 3Y29.44%
OCF growth 5Y22.55%

MANHATTAN ASSOCIATES INC / MANH Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MANHATTAN ASSOCIATES INC?

ChartMill assigns a fundamental rating of 7 / 10 to MANH.


What is the valuation status for MANH stock?

ChartMill assigns a valuation rating of 4 / 10 to MANHATTAN ASSOCIATES INC (MANH). This can be considered as Fairly Valued.


How profitable is MANHATTAN ASSOCIATES INC (MANH) stock?

MANHATTAN ASSOCIATES INC (MANH) has a profitability rating of 9 / 10.


How financially healthy is MANHATTAN ASSOCIATES INC?

The financial health rating of MANHATTAN ASSOCIATES INC (MANH) is 9 / 10.


What is the expected EPS growth for MANHATTAN ASSOCIATES INC (MANH) stock?

The Earnings per Share (EPS) of MANHATTAN ASSOCIATES INC (MANH) is expected to grow by 4.92% in the next year.